The group's principal activities are to develop, manufacture and market molecular diagnostics and genetic analysis products. The products are used in the discovery and validation of the genetic basis of disease and the delivery of personalized medicine. Genetic information delivered by the group provides a basis for understanding biological and medical functions in organisms. These products are based on invader(R) technology that has applications in genetics, chromosomal analysis, infectious disease, etc and it has been extended to agriculture/biotechnology also. The group markets and sells products through a combination of direct sales personnel and through collaborative relationships. The group has operations in the United States, Japan and the United Kingdom.
